The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 350:2637-2639 June 24, 2004 Number 26
NextNext

Pediatric Renal-Replacement Therapy — Coming of Age
Dawn S. Milliner, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by McDonald, S. P.
-PubMed Citation
Before the middle of the 20th century, the prospect that a child with end-stage renal disease (ESRD) would reach adulthood was essentially nil. Once dialysis and transplantation became available, that death sentence was lifted, as increasing numbers of children with ESRD were offered renal-replacement therapy. Now, most can expect to live for many years. The time course of this improvement in prognosis is reflected in the data from the Australia and New Zealand Dialysis and Transplant Registry presented by McDonald and Craig in this issue of the Journal (pages 2654–2662). These authors examined the long-term survival of children and adolescents . . . [Full Text of this Article]


Source Information

From the Division of Pediatric Nephrology, Mayo Clinic, Rochester, Minn.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.